Latest Osteonecrosis of the jaw Stories
This Approval Provides a New Treatment Option for a Patient Population With High Unmet Medical Need THOUSAND OAKS, Calif., Dec.
Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept.
ROSEMONT, Ill., June 18, 2014 /PRNewswire-USNewswire/ -- A new position paper on Medication Related Osteonecrosis of the Jaw (MRONJ) released by the American Association of Oral and Maxillofacial Surgeons,
Age and testing of hip bone mineral density (BDM) when postmenopausal women discontinue bisphosphonate therapy can help predict the likelihood of fractures over the next five years.
A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs).
As Reuters reported on August 30, a federal judge overseeing consolidated litigation over jaw injuries allegedly caused by Fosamax ordered hundreds of Fosamax lawsuits readied for trial.
On August 15, a New York federal judge ruled in Fosamax Multidistrict Litigation that generic manufacturers can be held liable for failing to match their warning labels to the brand name label.
Excess fat around the belly has recently been identified as a risk factor for bone loss.
A new study, published online July 16th in the journal Radiology, found that obese people with higher levels of fat in their liver, muscle tissue and blood also have higher amounts of fat in their